- Home
- DNTH vs SSYS Comparison
DNTH vs SSYS Comparison
Compare DNTH & SSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- SSYS
- Stock Information
- Founded
- DNTH 2015
- SSYS 1989
- Country
- DNTH United States
- SSYS United States
- Employees
- DNTH N/A
- SSYS N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- SSYS Computer peripheral equipment
- Sector
- DNTH Health Care
- SSYS Technology
- Exchange
- DNTH Nasdaq
- SSYS Nasdaq
- Market Cap
- DNTH 1.0B
- SSYS 942.7M
- IPO Year
- DNTH N/A
- SSYS 1994
- Fundamental
- Price
- DNTH $37.04
- SSYS $9.87
- Analyst Decision
- DNTH Strong Buy
- SSYS Strong Buy
- Analyst Count
- DNTH 9
- SSYS 3
- Target Price
- DNTH $61.57
- SSYS $14.33
- AVG Volume (30 Days)
- DNTH 969.3K
- SSYS 1.2M
- Earning Date
- DNTH 11-06-2025
- SSYS 11-12-2025
- Dividend Yield
- DNTH N/A
- SSYS N/A
- EPS Growth
- DNTH N/A
- SSYS N/A
- EPS
- DNTH N/A
- SSYS N/A
- Revenue
- DNTH $4,854,000.00
- SSYS $564,499,000.00
- Revenue This Year
- DNTH N/A
- SSYS N/A
- Revenue Next Year
- DNTH N/A
- SSYS $3.06
- P/E Ratio
- DNTH N/A
- SSYS N/A
- Revenue Growth
- DNTH 17.87
- SSYS N/A
- 52 Week Low
- DNTH $13.37
- SSYS $6.81
- 52 Week High
- DNTH $38.59
- SSYS $12.88
- Technical
- Relative Strength Index (RSI)
- DNTH 82.86
- SSYS 41.89
- Support Level
- DNTH $36.00
- SSYS $9.68
- Resistance Level
- DNTH $24.81
- SSYS $10.37
- Average True Range (ATR)
- DNTH 2.70
- SSYS 0.40
- MACD
- DNTH 1.31
- SSYS -0.06
- Stochastic Oscillator
- DNTH 90.18
- SSYS 13.74
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.